Biopharma spending on drug research is climbing, even as the projected revenue for those products is falling. According to consultancy Deloitte, various factors are at fault, but the biggest ones but the biggest one is the adjustment an industry is making to a post-pandemic environment.
Category Archive: As I See It
The pharma industry, known for its significant contributions to medical advancements and public health, is experiencing a concerning trend. A growing number of individuals are actively avoiding pursuing careers in pharma. This blog post delves into the underlying factors contributing to this shift and explores why so many people steer clear of this once-promising field.
Whether pharmaceutical companies should be banned from advertising is complex and debated. There are arguments on both sides, and it ultimately depends on one’s perspective and the specific regulations in a given country. Here are some key points to consider.
The high cost of patients skipping doctor’s appointments is a growing problem in the United States. According to a study by the Centers for Disease Control and Prevention (CDC), nearly one in five Americans (18%) missed a doctor’s appointment in the past year. This equates to over 100 million missed appointments each year.
EHRs were supposed to make our medical records digital, so sharing them among physicians would not be an issue, but so far EHRs have yet to live up to the promises. Sharing medical records between doctors can be challenging for several reasons, such as..
Whether or not pharmaceutical companies have the right to charge a lot of money for prescription drugs is a complex question with no easy answer. There are a number of factors to consider, including the cost of research and development, the risk of failure, and the need to recoup costs.
Gun violence is a major health concern in the United States. It is a leading cause of death for people of all ages, and it disproportionately affects young people, people of color, and people living in poverty. Gun violence also has a significant impact on the mental and physical health of survivors and witnesses.
The high price of new Alzheimer’s drugs will affect various stakeholders, including patients, healthcare systems, insurers, and the pharma industry. It will add billions to Medicare spending in a healthcare system trying to reduce costs. Here are some way it will impact our healthcare.